Joanna Breitstein

From her start as a physician working in apartheid-era South Africa to the dramatic turnaround and takeover of Millennium, Deborah Dunsire has lived a life that has defied all expectations.

Amgen's salvation just may be denosumab. We sit down to talk with the head scientists driving the drug.

In our first ever Emerging Leadership Awards, we profile 45 talented young professionals who will lead pharma into the next generation

Here's the saga of how market research, health outcomes, and dozens of other tools that connect the industry to patients came to be.

Industry insiders explain how pharma companies are reorganizing their salesforces in the wake of industry-wide layoffs

Science is the lifeblood of pharma, of course. But these days, science isn't just what you produce in your own labs. It's what you can license, buy, partner on, or gain through acquisition. Which means that, increasingly, deals are the lifeblood of pharma.